Piribedil (Trivastan) is a dopamine D2 agonist, used in the treatment of Parkinson's disease.

Piribedil Maleate is a direct agonist of dopamine that acts by showing selectivity for the D3 subtype.

Piribedil hydrochloride can be used in the parkinson's disease, circulatory disorders, cancers research. Piribedil hydrochloride inhibits MLL1 methyltransferase activity with EC50 value of 0.18 μM. Piribedil hydrochloride is a potent and orally active agonist of dopamine D2 and dopamine D3 as well as the antagonist of α2-adrenoceptors [1] [2] [3] [4].

Piribedil N-oxide, a metabolite of the dopamine receptor agonist piribedil, represents a chemical compound involved in the metabolic processing of its parent compound, piribedil.

Piribedil D8 is the deuterium labeled Piribedil, which is an agent of antiparkinsonian.

dopamine agonist